Webinar on EPO practice: G 2/21 and Inventive Step – Reliance on a Purported Technical Effect
In this on-demand webinar, we review selected decisions applying G 2/21 and share key takeaways for those working with European patent portfolios, particularly in the chemical and pharmaceutical sectors.
T 1561/23 - G 1/24 in action
In T 1561/23, the Technical Board of Appeal of the European Patent Office applied the principles of G 1/24 on using the description to interpret patent claims. Learn the key takeaways from the decision.
G 1/23 - reproducibility not a requirement for a commercial product to be prior art
The Enlarged Board of Appeal finds in G 1/23 that non-reproducible commercial products are part of the state of the art. Learn the key takeaways here.